Pharmeasy IPO: Pharmeasy was incorporated on 26 November 2014. PharmEasy is a Healthcare app from which consumers can order healthcare products, medicines, and lab tests online. PharmEasy is the biggest digital healthcare platform that solves the major health care needs of consumers. PharmEasy offers 1 lakh+ medicine and health products across various categories. You can also check GMP OF IPO for Pharmeasy IPO Grey Market Premium.
They Have over 25 Million Registered Users, 8.8 Million PharmEasy Orders, 2.4 Million Transacting customers. They deliver their products in 1000+ cities and towns with over 22000 pin codes.
Pharmeasy IPO Services:
PharmEasy is a consumer healthcare app that provides consumers with on-demand, OTC pharmaceutical, home-delivered access to a wide range of prescription, comprehensive diagnostic test services, other consumer healthcare products, and teleconsultations thereby serving their healthcare needs. They offer guaranteed delivery to consumers in 24-48* hrs.
We recommend investors check Retail and HNI numbers before investing in IPO. Investors may apply for this IPO with risk. You can also check Pharmeasy IPO Allotment Status from this page.
Top Brokerage Firm Reviews About P.E. Analytics IPO
- Chittorgarh IPO: – N/A
- Arihant Capital: – N/A
- Angel Broking: – N/A
- Capital Market: – N/A
- Ventura Securities: – N/A
- ICICI Securities: – N/A
- Choice Broking: – N/A
- Marwadi Financial: – N/A
Pharmeasy IPO: Pharmeasy is one of the leading pharmacy platforms that offer 1 lakh+ medicine and health products across various categories. The ultimate goal of PharmEasy is to provide affordable healthcare to one and all.
Last few years company faces a loss so it might one of the concerns but nowadays this sector is doing well so we can predict a jump in gross revenues in upcoming years.
Pharmeasy IPO GMP Live Rates day by day with Kotak rates.
Pharmeasy IPO Date & Price Band
You can find all the details as well as the price band of this IPO from this page. This IPO will open in — 2022 and close in — 2022.
|IPO Size:||Approx ₹6250 Crores|
|Fresh Issue:||Approx ₹- Crores|
|Offer for Sale:||Approx – Equity Shares|
|Face Value:||₹1 Per Equity Share|
|Price Band:||₹- to ₹- Per Share|
|Listing on:||BSE & NSE|
|DRHP Draft Prospectus:||Click Here|
|RHP Draft Prospectus:||Click Here|
This IPO’s total size will be Approx ₹6250 Crores and the face value for this will be ₹1 Per Equity Share. You can also get the DRHP & RHP Draft documents from the above table.
Pharmeasy IPO Allotment, Listing & Important Dates
In this table, you will get a clear idea about When Pharmeasy IPO will open & close? allotment date and all important dates related to this IPO.
|IPO Open Date:||2022|
|IPO Close Date:||2022|
|Basis of Allotment:||2022|
|Credit to Demat Account:||2022|
|IPO Listing Date:||2022|
Pharmeasy IPO Lot Size / Market Lot
|Minimum Lot Size:||Minimum – Shares for 1 lot|
|Minimum Amount:||₹- for 1 lot|
|Maximum Lot Size:||Maximum – Shares for 13 lot|
|Maximum Amount:||₹- for 13 lot|
Pharmeasy Company Details & Financials
Here you will find detailed company analytics as well as financial reports. How well the company has performed in the last few years.
Pharmeasy Company Address
API Holdings Limited
902, 9th Floor, Raheja Plaza 1, B-Wing,
Opposite R-City Mall, L.B.S. Marg,
Ghatkopar West, Mumbai 400 086,
Tel: +91 22 6255 6255
Contact Person: Drashti Shah
Company Secretary and Chief Compliance Officer
E-mail: [email protected]
Corporate Identity Number: U60100MH2019PLC323444
Pharmeasy Comany Financial Reports ( ₹ in Crores )
Pharmeasy Company Promoter
- The Company does not have an Identifiable Promoter.
Pharmeasy IPO Registrar
Link Intime India Private Limited
C-101, 247 Park, L B S Marg,
Vikhroli (West), Mumbai 400 083,
Tel: +91 22 4918 6000
E-mail: [email protected]
Investor grievance ID: [email protected]
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Pharmeasy IPO Allotment Status
You can check the Pharmeasy IPO Allotment Status Very Easily. Click Here and you can check the status from the N/A website.